Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $877.20 | 3 | 91.8% |
| Food and Beverage | $77.94 | 6 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Zimmer Biomet Holdings, Inc. | $877.20 | 3 | $0 (2023) |
| Novo Nordisk Inc | $24.46 | 2 | $0 (2023) |
| Abbott Laboratories | $15.87 | 1 | $0 (2022) |
| Phadia US Inc. | $15.37 | 1 | $0 (2017) |
| AbbVie Inc. | $11.87 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $10.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $890.04 | 4 | Zimmer Biomet Holdings, Inc. ($877.20) |
| 2022 | $15.87 | 1 | Abbott Laboratories ($15.87) |
| 2021 | $11.87 | 1 | AbbVie Inc. ($11.87) |
| 2020 | $11.62 | 1 | Novo Nordisk Inc ($11.62) |
| 2017 | $25.74 | 2 | Phadia US Inc. ($15.37) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes | ||||||
| 09/12/2023 | Zimmer Biomet Holdings, Inc. | — | Travel and Lodging | In-kind items and services | $285.00 | General |
| 09/08/2023 | Zimmer Biomet Holdings, Inc. | — | Travel and Lodging | In-kind items and services | $558.20 | General |
| 09/08/2023 | Zimmer Biomet Holdings, Inc. | — | Travel and Lodging | In-kind items and services | $34.00 | General |
| 01/17/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Diabetes Care | ||||||
| 01/14/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Diabetes | ||||||
| 11/08/2017 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Allergy/Immunology | ||||||
| 04/11/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 295 | 834 | $100,152 | $40,969 |
| 2022 | 10 | 424 | 1,209 | $138,515 | $54,199 |
| 2021 | 11 | 536 | 1,475 | $161,937 | $71,581 |
| 2020 | 10 | 623 | 2,055 | $205,844 | $86,028 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 366 | $73,200 | $28,562 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 92 | $13,800 | $5,312 | 38.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 19 | $5,700 | $2,663 | 46.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 75 | 223 | $2,230 | $1,856 | 83.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $2,300 | $1,818 | 79.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 77 | $2,310 | $745.69 | 32.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 27 | $540.00 | $10.23 | 1.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 18 | $72.00 | $1.50 | 2.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 491 | $98,200 | $40,647 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 208 | $31,200 | $10,976 | 35.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 37 | 101 | $3,030 | $904.71 | 29.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 99 | 269 | $2,690 | $797.31 | 29.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 13 | 13 | $975.00 | $411.19 | 42.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $390.00 | $364.52 | 93.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 22 | $638.00 | $75.45 | 11.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 19 | 42 | $840.00 | $11.44 | 1.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 13 | 22 | $440.00 | $9.16 | 2.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 19 | 28 | $112.00 | $2.02 | 1.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 640 | $118,400 | $53,617 | 45.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 225 | $30,540 | $13,593 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $2,400 | $1,566 | 65.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 45 | 123 | $3,690 | $1,192 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 119 | 283 | $2,830 | $849.00 | 30.0% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 14 | 14 | $1,050 | $419.16 | 39.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $420.00 | $227.64 | 54.2% |
About Dr. Danny West, MD
Dr. Danny West, MD is a Family Medicine healthcare provider based in Pembroke, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639178106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny West, MD has received a total of $955.14 in payments from pharmaceutical and medical device companies, with $890.04 received in 2023. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($877.20).
As a Medicare-enrolled provider, West has provided services to 1,878 Medicare beneficiaries, totaling 5,573 services with total Medicare billing of $252,776. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Pembroke, NC
- Active Since 07/18/2005
- Last Updated 01/17/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1639178106
Products in Payments
- FREESTYLE LIBRE 2 (Device) $15.87
- ImmunoCAP (Device) $15.37
- Rybelsus (Drug) $12.84
- CREON (Drug) $11.87
- Ozempic (Drug) $11.62
- FARXIGA (Drug) $10.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pembroke
Dr. Steven Kaitz, Md, MD
Family Medicine — Payments: $3,092
Aaron Locklear, M.d, M.D
Family Medicine — Payments: $2,682
Sarah Flint, Fnp-C, FNP-C
Family Medicine — Payments: $2,125
Dr. Nicole Wood, Md, MD
Family Medicine — Payments: $2,093
Harley Hendrix, Md, MD
Family Medicine — Payments: $636.07
Jennifer Sabir, Md, MD
Family Medicine — Payments: $522.10